首页> 美国卫生研究院文献>Acta Myologica >Complete resolution of left atrial appendage thrombosis with oral dabigatran etexilate in a patient with Myotonic Dystrophy type 1 and atrial fibrillation
【2h】

Complete resolution of left atrial appendage thrombosis with oral dabigatran etexilate in a patient with Myotonic Dystrophy type 1 and atrial fibrillation

机译:1型强直性肌营养不良合并心房颤动的患者口服达比加群酯可完全解决左心耳血栓形成

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Myotonic Dystrophy type 1 (DM1) is the most common muscular dystrophy in adult life characterized by muscle dysfunction and cardiac conduction abnormalities. Atrial fibrillation frequently occurs in DM1 patients. It’s related to the discontinuous and inhomogeneous propagation of sinus impulses and to the prolongation of atrial conduction time, caused by progressive fibrosis and fatty replacement of the myocardium. AF predisposes to a hyper-coagulable state and to an increased risk of thromboembolism. We report the first case of complete resolution of left atrial appendage thrombosis with oral dabigatran etexilate in a myotonic dystrophy type I patient with atrial fibrillation scheduled for transesophageal echocardiogram-guided direct current cardioversion.
机译:1型强直性肌营养不良症(DM1)是成​​人生活中最常见的肌营养不良症,其特征是肌肉功能障碍和心脏传导异常。 DM1患者经常发生房颤。它与窦性冲动的不连续和不均匀传播以及由于进行性纤维化和心肌脂肪替代引起的心房传导时间延长有关。 AF易处于高凝状态,并增加血栓栓塞的风险。我们报道了首例完全性消融的左房附件血栓形成与口服达比加群酯联合治疗的强直性营养不良的I型房颤患者,计划经食管超声心动图指导直流电复律。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号